Scientists test new path for controlling multiple sclerosis
NCT ID NCT04178005
Summary
This study is looking at what happens when people with relapsing forms of multiple sclerosis (MS) switch from one specific medication (natalizumab) to another (cladribine tablets). It will follow 40 patients for about two years to check the safety of the switch and see how it affects their immune cells and MS symptoms. The goal is to gather information to help doctors better manage MS over the long term.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
College Park Family Care Center Physicians Group
Overland Park, Kansas, 66212, United States
-
UT Southwestern Medical center
Dallas, Texas, 75390, United States
Conditions
Explore the condition pages connected to this study.